ArticleFrontiers in medicine2026
Hemorrhagic fever with renal syndrome complicated by reversible secondary hyperparathyroidism during renal recovery: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemorrhagic fever with renal syndrome (HFRS) is a hantavirus-induced zoonosis characterized by fever, hemorrhagic manifestations, and acute kidney injury (AKI). Endocrine sequelae have been increasingly recognized after HFRS, yet parathyroid dysfunction has rarely been reported. Secondary hyperparathyroidism (SHPT) is classically associated with chronic kidney disease, but severe AKI may also disrupt mineral metabolism and trigger abnormal parathyroid hormone (PTH) responses. In this study, we report a case of secondary hyperparathyroidism suspected to be triggered by hemorrhagic fever with renal syndrome, a presentation that has been rarely described in the literature. In addition, we provide a review of the existing evidence regarding endocrine involvement in HFRS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.